Background: Rheumatic valvular stenosis is the most common valvular heart disease which is encountered in pregnant patients in our country. Combination of severe mitral or aortic stenosis (AS) and physiological changes that accompany pregnancy amplifies problems.
BACKGROUND
Prevalence of heart disease in pregnancy ranges from 0.3 to 3.5%. 1 As the severity of heart disease increases, the cardiac complication rate increases. 2 
Mitral stenosis (MS)
is the most common lesion in rheumatic heart disease (RHD), whereas AS is a relatively rare lesion. Patients with severe stenotic valve lesions do not tolerate well the physiological changes of pregnancy and the chance of cardiac failure increases from the second trimester onward. Timely termination of pregnancy may help reduce this additional burden on the heart. However, refractory cardiac failure may ensue and emergency CS and VR remain the only choice in such a situation. The anesthetic management of combined surgery in the same sitting has many challenges as this report of two cases reveals.
CASE REpORT
We present a report of two patients who underwent simultaneous CS and VR surgery. The clinical details of both patients are given in Table 1 .
Case 1
A 23-year-old primigravida, diagnosed case of severe MS, with valve area of 1. 
RIA

Case 2
A 25-year-old second gravida with history of balloon mitral valvotomy for MS and CS in previous pregnancy was admitted for elective CS in view of heart disease. The 2D-ECHO revealed severe AS with peak and mean gradient of 79 and 45 mm Hg respectively. After multidisciplinary discussion, it was decided to do elective CS and aortic valve replacement (AVR) simultaneously.
Clinical Management
After written informed consent, both patients were prepared for surgery. Monitoring included 5-lead electrocardiogram, pulse oximetry, noninvasive BP, Entropy ® , urine output, and fetal heart rate (FHR). The first patient was transferred to the cardiac operation theater in propped up position with CPAP. She was extremely anxious with HR of 150 to 160 beats/minute. Diltiazem 12.5 mg was given titrated to reduce the HR to around 100/min. Midazolam 0.5 mg and fentanyl 50 µg were given for anxiolysis. Due to orthopnea, right internal jugular vein was cannulated in propped up position and femoral arterial line was taken under local anesthesia. In the second patient, invasive lines were secured in supine position. The FHR remained between 120 and 130 beats/minute. The operating table was given a left tilt to prevent inferior vena cava compression. Further management was similar in both patients. Etomidate 0.3 mg/kg and rocuronium 1.2 mg/kg were administered intravenously for rapid sequence intubation. Both patients were ventilated with 100% oxygen, maintaining normocarbia till the baby was delivered, which took 7 and 13 minutes respectively.
The Apgar score of the first baby was 3 and 6 at 1 and 5 minutes respectively. The baby was intubated and ventilated. The baby could be extubated after 15 minutes due to clinical improvement. The Apgar score of the second baby was 3 and 5 at 1 and 5 minutes. The baby was intubated and required ventilator support for 6 hours.
After baby delivery, both patients were ventilated using air: oxygen maintaining FiO 2 0.7. Midazolam 1 mg and fentanyl 150 µg were given. Anesthesia was maintained with fentanyl 5 to 10 µg/kg/hour and vecuronium 0.08 µg/kg/ minute maintaining Entropy ® between 40 and 60. Slow oxytocin infusion was started. Furosemide 20 mg was administered. Abdomen was closed after thorough hemostasis. Fentanyl 100 µg was repeated prior to sternotomy. After instituting cardiopulmonary bypass (CPB), MVR was performed in the first patient and AVR in the second patient was performed using a bio prosthetic valve, maintaining a perfusion pressure of 50 to 60 mm Hg. The details of CPB are mentioned in Table 2 . Both patients were weaned off CPB. Both the patients required dopamine 3 µg/kg/ minute for weaning and adrenaline 0.06 µg/kg/min was required in the first case. Hemodynamic parameters of the patients, before and after CS and VR, are shown in Table 3 . Furosemide 60 mg and torsemide 20 mg were administered postweaning from CPB to the first patient. The post-CPB hemoglobin of both patients was 7 gm/dL; hence, both received one unit of packed red cells each. The patients were electively ventilated and extubated 14 and 16 hours later respectively. No unusual bleeding was encountered in the perioperative period. Inotropes were gradually tapered and stopped. The first patient was started on warfarin, torsemide, metoprolol, diltiazem, and aspirin. The 2D-ECHO on postoperative day 12 showed persistence of AF and reduction of mean PAP to 38 mm Hg. The patient was discharged on day 22. The second patient was started on aspirin, warfarin, torsemide, and amiodarone, as she developed AF postsurgery. Postoperative 2D-ECHO revealed reduction in peak and mean pressure gradients across aortic valve to 24 and 14 mm Hg and mean PAP of 36 mm Hg. She was discharged on day 20.
DISCUSSION
Rheumatic heart disease is the main cause of heart disease in Indian pregnant patients (88%). 3 Our patients were classified as stage D valvular heart disease (severe symptomatic MS and severe symptomatic AS respectively) as per the 2014 American Heart Association/American College of Cardiology (AHA/ACC) guidelines for management of patients with valvular heart disease 4 and were at extremely high risk (class IV) of maternal mortality or morbidity. 5 Pregnant patients with severe valve stenosis should be monitored in a tertiary care center with a dedicated team of cardiologists, surgeons, anesthesiologists, and obstetricians with expertise in the management of high-risk cardiac patients during pregnancy. 5 Mitral valve surgery may be considered for patients with severe MS (mitral valve area <1.5 cm 2 , stages C and D) who have had recurrent embolic events while receiving adequate anticoagulation. 4 The AVR is recommended in patients of severe AS with symptoms of heart failure, syncope, exertional dyspnea, angina, or syncope on history or on exercise testing and with mean pressure gradient of 40 mm Hg or higher. 4 The risk of cardiac failure in pregnant patient with heart disease increases from the second trimester onward. Pregnancy is a hypercoagulable state. Despite maintaining prothrombin times 2.0 to 2.5 times the control value, some patients may demonstrate thromboembolic episodes. 6 In the first patient, steroids had been given for fetal lung maturity cases and in the second, the fetus had reached the period of viability. Hence, it was decided to proceed ahead with CS and MVR/AVR to remove the additional load placed on the heart secondary to the pregnancy. The following issues have to be considered while planning combined MVR with CS: (1) anesthetic considerations due to severe MS with AF and LA thrombus; (2) increased risk of fetal hypoxia secondary to maternal hypoxia resulting from pulmonary congestion. Neonatal respiratory depression due to transfer of anesthetic drugs across the placenta compounds the problem; (3) worsening of cardiac failure due to autotransfusion from uterus after baby delivery; (4) increased risk of uterine bleeding.
Meticulous control of HR is needed in MS and AS to maintain left ventricular end diastolic volume and, subsequently, cardiac output. Despite digoxin and metoprolol, the first patient's ventricular rate was 110 to 120 beats/minute and anxiety worsened it. Calcium channel blockers are indicated for rate control in pregnancy only when beta-blockers and digoxin are unsuccessful. 7 Hence, diltiazem was used for rate control. Remifentanil provides cardiovascular stability with minimal side 8 Low doses of midazolam and fentanyl were given since they have no adverse effect on neonatal outcome and remifentanil was not available. 9 High dose of fentanyl was found to cause severe neonatal respiratory depression necessitating mechanical ventilation. 10 Mitral stenosis and AS are low cardiac output states. Most anesthetic agents used for induction result in hypotension which can reduce uteroplacental blood flow. The combined effect of this low cardiac output state and hypotension may adversely affect the neonatal outcome. Other authors have reported the use of thiopentone for induction which causes hypotension and can worsen tachycardia. [10] [11] [12] Also, high dose of fentanyl, when used for induction, can lead to severe neonatal respiratory depression. 10 Etomidate, which has no effect on the sympathetic nervous system, was used to avoid hypotension. Etomidate has been safely used for induction in pregnant cardiac patients. 13 Heparinization needed during CPB increases the risk of uterine bleeding after CS. We did not encounter increased bleeding similar to the findings of other authors. 10, 12 Inhalational anesthetics and inotropes with beta-2 agonist effect cause uterine relaxation which may aggravate bleeding. Potential uterine relaxation by inhalational anesthetics was avoided by using fentanyl infusion for maintenance of anesthesia with additional dose of midazolam after baby delivery. We chose oxytocin infusion as methylergometrine increases systemic and pulmonary vascular resistance. There was an increase in the central venous pressure and peak airway pressure (from 14 to 24 cm H 2 O) and slight fall in SpO 2 after delivery (Table 1) in the first patient. This can be explained by the autotransfusion which occurs due to contraction of the uterus. Additional furosemide was administered to counter this effect.
CONCLUSION
A combination of etomidate with low-dose fentanyl and diltiazem for HR control helps in achieving the tight balance between preservation of maternal hemodynamics and minimizing neonatal respiratory depression in patients undergoing combined CS with MVR.
CLINICAL SIGNIfICANCE
A thorough knowledge of the pathophysiology of both RHD and pregnancy, prudent choice of anesthesia technique, along with close maternal and fetal monitoring and a multidisciplinary approach can lead to a successful outcome.
